Atlanta

Epidemiological Brief

As of 27 July 2026, Atlanta is classified at MEDIUM epidemic risk (composite score 25.6). Influenza-like illness is the leading signal at 7.1% ILI prevalence — 28.6% of the historical peak — indicating sustained summer influenza activity above typical baseline. Measles incidence is low but present at 0.28 cases per 100,000 (35.4% of the reference threshold), sufficient to maintain vaccination verification protocols at all venues. Mpox is detected at 0.31 cases per 100,000, with the adjusted contribution attenuated to 20% by the mitigation adjustment factor reflecting community immunity and vaccination uptake. Pertussis incidence stands at 1.39 cases per 100,000, and COVID-19 activity is low at 0.39 cases per 100,000. Dengue cases are sparse (0.03 cases per 100,000), representing travel importations only. Wastewater-based epidemiology (ATCP-73RE) is actively monitoring COVID-19 and influenza. No international arrivals were recorded in the current OpenSky data cycle; alternate monitoring channels remain active. Warm and humid conditions (26 °C, 82% humidity, 1.8 mm precipitation) support respiratory pathogen circulation. Recommended actions include reinforcing MMR verification, maintaining mpox clinical pathways at fan medical posts, enhancing influenza rapid testing, and continuing pertussis outbreak surveillance in coordination with the Georgia Department of Public Health throughout the event period.

Model SCEME v3.1 · Updated July 27, 2026

Please consult a local doctor or pharmacist for guidance and medication.